Search Results - "Ahlquist, A"

Refine Results
  1. 1

    Frequency of Decreased Susceptibility and Resistance to Echinocandins among Fluconazole-Resistant Bloodstream Isolates of Candida glabrata by PFALLER, M. A, CASTANHEIRA, M, LOCKHART, S. R, AHLQUIST, A. M, MESSER, S. A, JONES, R. N

    Published in Journal of Clinical Microbiology (01-04-2012)
    “…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  2. 2

    Magnitude of Missed Esophageal Adenocarcinoma After Barrett’s Esophagus Diagnosis: A Systematic Review and Meta-analysis by Visrodia, Kavel, Singh, Siddharth, Krishnamoorthi, Rajesh, Ahlquist, David A, Wang, Kenneth K, Iyer, Prasad G, Katzka, David A

    Published in Gastroenterology (New York, N.Y. 1943) (01-03-2016)
    “…Background & Aims A proportion of patients with Barrett’s esophagus (BE) are diagnosed with esophageal adenocarcinoma (EAC) within 1 year of an endoscopic…”
    Get full text
    Journal Article
  3. 3

    Molecular markers for colorectal cancer screening by Dickinson, Brandon T, Kisiel, John, Ahlquist, David A, Grady, William M

    Published in Gut (01-09-2015)
    “…Colorectal cancer (CRC), although a significant cause of morbidity and mortality worldwide, has seen a declining incidence and mortality in countries with…”
    Get more information
    Journal Article
  4. 4

    Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis by Kim, Minsuk, Vogtmann, Emily, Ahlquist, David A, Devens, Mary E, Kisiel, John B, Taylor, William R, White, Bryan A, Hale, Vanessa L, Sung, Jaeyun, Chia, Nicholas, Sinha, Rashmi, Chen, Jun

    Published in mBio (18-02-2020)
    “…Colorectal adenomas are precancerous lesions of colorectal cancer (CRC) that offer a means of viewing the events key to early CRC development. A number of…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    Multitarget stool DNA test: clinical performance and impact on yield and quality of colonoscopy for colorectal cancer screening by Johnson, David H., MD, Kisiel, John B., MD, Burger, Kelli N., BS, Mahoney, Douglas W., MS, Devens, Mary E., CCRP, Ahlquist, David A., MD, Sweetser, Seth, MD

    Published in Gastrointestinal endoscopy (01-03-2017)
    “…Background and Aims Multitarget stool DNA (MT-sDNA) testing is now approved by the U.S. Food and Drug Administration for average-risk colorectal cancer…”
    Get full text
    Journal Article
  9. 9

    Nanopore-Based Assay for Detection of Methylation in Double-Stranded DNA Fragments by Shim, Jiwook, Kim, Younghoon, Humphreys, Gwendolyn I, Nardulli, Ann M, Kosari, Farhad, Vasmatzis, George, Taylor, William R, Ahlquist, David A, Myong, Sua, Bashir, Rashid

    Published in ACS nano (27-01-2015)
    “…DNA methylation is an epigenetic modification of DNA in which methyl groups are added at the 5-carbon position of cytosine. Aberrant DNA methylation, which has…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Stool screening for colorectal cancer: Molecular approaches by Osborn, Neal K., Ahlquist, David A.

    “…Assay of molecular markers in stool represents a promising noninvasive approach to screen colorectal cancer. Given that neoplasms exfoliate abundantly into the…”
    Get full text
    Journal Article
  12. 12

    Cost-Effectiveness of Multitarget Stool DNA Testing vs Colonoscopy or Fecal Immunochemical Testing for Colorectal Cancer Screening in Alaska Native People by Redwood, Diana G., Dinh, Tuan A., Kisiel, John B., Borah, Bijan J., Moriarty, James P., Provost, Ellen M., Sacco, Frank D., Tiesinga, James J., Ahlquist, David A.

    Published in Mayo Clinic proceedings (01-05-2021)
    “…To estimate the cost-effectiveness of multitarget stool DNA testing (MT-sDNA) compared with colonoscopy and fecal immunochemical testing (FIT) for Alaska…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    Endoscopic overestimation of colorectal polyp size by Anderson, Bradley W., MD, Smyrk, Thomas C., MD, Anderson, Kari S, Mahoney, Douglas W., MS, Devens, Mary E., BA, Sweetser, Seth R., MD, Kisiel, John B., MD, Ahlquist, David A., MD

    Published in Gastrointestinal endoscopy (01-01-2016)
    “…Background and Aims Polyp size ≥1 cm triggers more frequent colonoscopic surveillance, yet size is typically based on subjective endoscopic estimates. We…”
    Get full text
    Journal Article
  18. 18

    Molecular detection of pancreatic neoplasia: Current status and future promise by Majumder, Shounak, Chari, Suresh T, Ahlquist, David A

    Published in World journal of gastroenterology : WJG (28-10-2015)
    “…Pancreatic cancer is usually diagnosed at an advanced stage and curative resection is feasible in only a small minority of patients at the time of diagnosis…”
    Get full text
    Journal Article
  19. 19

    A Comprehensive Approach to Sequence-oriented IsomiR annotation (CASMIR): demonstration with IsomiR profiling in colorectal neoplasia by Wu, Chung Wah, Evans, Jared M, Huang, Shengbing, Mahoney, Douglas W, Dukek, Brian A, Taylor, William R, Yab, Tracy C, Smyrk, Thomas C, Jen, Jin, Kisiel, John B, Ahlquist, David A

    Published in BMC genomics (25-05-2018)
    “…MicroRNA (miRNA) profiling is an important step in studying biological associations and identifying marker candidates. miRNA exists in isoforms, called…”
    Get full text
    Journal Article
  20. 20